ID   L5178Y/ASP
AC   CVCL_C8YE
SY   L5178Y(Asnase); L5178YF/A-ase
DR   Wikidata; Q123032885
RX   PubMed=6724617;
RX   PubMed=11945363;
CC   Selected for resistance to: DrugBank; DB00023; Escherichia coli asparaginase.
CC   Transformant: ChEBI; CHEBI_34342; 3-methylcholanthrene (3-MC; 20-methylcholanthrene; 20-MC; MCA).
CC   Derived from site: In situ; Thymus; UBERON=UBERON_0002370.
CC   Cell type: T-cell; CL=CL_0000084.
CC   Breed/subspecies: DBA/2.
DI   NCIt; C134997; Mouse thymic lymphoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_C8YG ! L5718YF
SX   Female
AG   8M
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
RX   PubMed=6724617; DOI=10.1007/BF02619582;
RA   Ankel E.G., Zirneski J., Ring B.J., Holcenberg J.S.;
RT   "Effect of asparaginase on cell membranes of sensitive and resistant
RT   mouse lymphoma cells.";
RL   In Vitro 20:376-384(1984).
//
RX   PubMed=11945363; DOI=10.1016/0014-5793(70)80422-7;
RA   Kessel D.H., Bosmann H.B.;
RT   "Effects of L-asparaginase on protein and glycoprotein synthesis.";
RL   FEBS Lett. 10:85-88(1970).
//